Document is current
Any future updates will be listed below
-
Authors
Megas, Stathis https://orcid.org/0000-0002-2038-3040
Chen, Daniel G. https://orcid.org/0000-0001-6660-6257
Polanski, Krzysztof
Asadollahzadeh, Hesam
Eliasof, Moshe
Schönlieb, Carola-Bibiane
Teichmann, Sarah A. https://orcid.org/0000-0002-6294-6366
- License Information
-
More Information
Article History
Received: 7 August 2025
Accepted: 3 February 2026
First Online: 18 March 2026
Competing interests
: In the past three years, S.A.T. has received remuneration for scientific advisory board membership from Sanofi, GlaxoSmithKline, Foresite Labs and Qiagen. S.A.T. is a co-founder and holds equity in Transition Bio and Ensocell. From January 8th of 2024, S.A.T. is a part-time employee of GlaxoSmithKline. The remaining authors declare no competing interests.
